XML 70 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning balance (deficit) at Dec. 31, 2010 $ 29,129 $ 16 $ 97,291 $ 103 $ (68,206) $ (75)
Beginning balance at Dec. 31, 2010 15,775,645 15,775,645        
Increase (Decrease) in Stockholders' Equity            
Net income 17,476       17,098 378
Foreign currency translation adjustments (390)     (390)    
Cash flow hedge (31)     (31)    
Repurchase of common stock (7,544) (1) (7,543)      
Repurchase of common stock (in shares) (461,512) (461,512)        
Proceeds from exercise of stock options 217   217      
Proceeds from exercise of stock options (in shares) 68,322 68,322        
Issuance of stock grants 245   245      
Issuance of stock grants (in shares) 14,009 14,009        
Vested restricted stock units (in shares) 68,400 68,400        
Non-cash stock-based compensation related to restricted stock units 2,206   2,206      
Tax benefit from exercise of stock options and vesting of restricted stock units 246   246      
Distribution to noncontrolling interest (388)         (388)
Ending balance (deficit) at Dec. 31, 2011 41,166 15 92,662 (318) (51,108) (85)
Ending balance at Dec. 31, 2011 15,464,864 15,464,864        
Increase (Decrease) in Stockholders' Equity            
Net income 2,374       1,340 1,034
Foreign currency translation adjustments 2     2    
Cash flow hedge (65)     (65)    
Shares issued-Central Merger 140,726 7 140,719      
Shares issued-Central Merger (in shares) 6,161,332 6,161,332        
Proceeds from exercise of stock options 526   526      
Proceeds from exercise of stock options (in shares) 81,023 81,023        
Issuance of stock grants 165   165      
Issuance of stock grants (in shares) 8,751 8,751        
Vested restricted stock units (in shares) 154,800 154,800        
Non-cash stock-based compensation related to restricted stock units 1,857   1,857      
Tax benefit from exercise of stock options and vesting of restricted stock units 446   446      
Purchase of Central shares of noncontrolling interest 677         677
Distribution to noncontrolling interest (874)         (874)
Ending balance (deficit) at Dec. 31, 2012 187,000 22 236,375 (381) (49,768) 752
Ending balance at Dec. 31, 2012 21,870,770 21,870,770        
Increase (Decrease) in Stockholders' Equity            
Net income 14,765       12,089 2,676
Foreign currency translation adjustments (463)     (463)    
Cash flow hedge 962     962    
Issuance of stock grants (in shares) 15,576 15,576        
Vested restricted stock units (in shares) 90,965 90,965        
Non-cash stock-based compensation related to restricted stock units 4,092   4,092      
Tax benefit from exercise of stock options and vesting of restricted stock units 198   198      
Distribution to noncontrolling interest (2,843)         (2,843)
Ending balance (deficit) at Dec. 31, 2013 $ 203,711 $ 22 $ 240,665 $ 118 $ (37,679) $ 585
Ending balance at Dec. 31, 2013 21,977,311 21,977,311